← Leaderboards
Georgios Triantafyllou
Brigham And Women'S Hospital
$170,538
Attributed
$170,538
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $89.5K · FY2022–24$100K$75K$50K$25K$0
'22
'23
'24
Funding mix
By agency
NIH$170,538 · 1
By mechanism
F32$170,538 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Susan S Redline$76,698,471
- Laura Elizabeth Fredenburgh$4,191,382
- Bradley Wertheim$1,908,343
- Amil M Shah$21,763,052
- William Michael Oldham$3,432,068
Others in their field
Other Rising Stars on “Enzymes”
- Jason Dickens · Duke University$12,259,409
- John Alam · Eip Pharma, Inc.$10,411,018
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Kenneth Schultz · Trethera Corporation$8,384,949
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Jennifer Wierman · Cornell University$7,750,000
Research focus
EnzymesAcuteEndotheliumAntioxidantsApoptosisAnimal ExperimentsAnimalsAnatomyCalciumCardiacCareer DevelopmentCell Culture TechniquesCell ProliferationArterial StiffnessBlood CapillariesClinical Trials DesignBlood VesselsCyclic GmpDown-RegulationEchocardiographyEducational WorkshopEffective TherapyEfracEvaluation
Grant awards (2)
Targeting mitochondria-derived reactive oxygen species as a therapy for combined pre- and post-capillary pulmonary hypertension$89,488
F32 · FY2024 · HL · contact PI
Targeting mitochondria-derived reactive oxygen species as a therapy for combined pre- and post-capillary pulmonary hypertension$81,050
F32 · FY2022 · HL · contact PI